INTS1 anticorps (AA 150-200)

N° du produit ABIN7451568

Détail du produit anti-INTS1 anticorps

Antigène: INTS1 (Integrator Complex Subunit 1 (INTS1))

Épitope: AA 150-200

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp INTS1 est non-conjugé

Application: Western Blotting (WB), Immunoprecipitation (IP)

Fonction: Rabbit anti-INT1 Antibody, Affinity Purified

Purification: Affinity Purified

Immunogène: between AA 150 and 200

Isotype: IgG

Information d'application

Indications d'application:

IP: 2 - 5 μg/mg lysate

WB: 1:1,000 - 1:2,500

Restrictions: For Research Use only

Stockage

Concentration: 1000 μg/mL

Buffer: Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Date de péremption: 12 months

Détails sur INTS1

Antigène: INTS1 (Integrator Complex Subunit 1 (INTS1))

Autre désignation: INT1 (INTS1 Produits)

Synonymes: anticorps fa14a05, anticorps wu:fa14a05, anticorps wu:fa55a06, anticorps DDBDRAFT_0218704, anticorps DDBDRAFT_0234073, anticorps DDB_0218704, anticorps DDB_0234073, anticorps INTS1, anticorps INT1, anticorps NET28, anticorps 1110015K06Rik, anticorps integrator complex subunit 1, anticorps phage-related integrase, anticorps INTS1, anticorps ints1, anticorps intS1, anticorps Ints1

Sujet: Background: INT1 was first identified as KIAA1440, a hypothetical protein predicted from the in silico analysis of long cDNAs isolated in the Kazusa cDNA sequencing project. Targeted disruption of INT1 results in growth arrest at the early blastocyst stage, activated caspase-3/7 that results in apoptosis, and impaired processing of U2 snRNA. INT1 has been demonstrated to be the largest subunit of the integrator complex which functions to mediate U1 and U2 snRNA 3'end processing.

ID gène: 26173

NCBI Accession: XP_291222

UniProt: Q8N201